OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
Vali Musazadeh, Neda Roshanravan, Parvin Dehghan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 87

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 52

The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41

Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
Giselle S. Escouto, Gabriela Z. Port, Cristiane Valle Tovo, et al.
Journal of Nutrition (2023) Vol. 153, Iss. 7, pp. 1984-1993
Open Access | Times Cited: 22

Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: An umbrella meta-analysis
Meysam Zarezadeh, Vali Musazadeh, Amir Hossein Faghfouri, et al.
Pharmacological Research (2022) Vol. 183, pp. 106397-106397
Closed Access | Times Cited: 29

Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis
Haotian Huang, Yang Liu, Wen Zhi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5

The effects of the gut bacterial product, gassericin A, on obesity in mice
Valeh Mahdavi, Hamid Reza Kazerani, Fereidoun Taghizad, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Jiayi Liu, Anding Wu, Jingjing Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26

In-vitro and in-vivo antibacterial activity of potential probiotic Lactobacillus paracasei against Staphylococcus aureus and Escherichia coli
Shadi Shahverdi, Amir Abbas Barzegari, Reza Vaseghi Bakhshayesh, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14641-e14641
Open Access | Times Cited: 14

Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study
Jia‐Hung Lin, Chi-Huei Lin, Yi‐Wei Kuo, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307181-e0307181
Open Access | Times Cited: 3

The effect of cinnamon consumption on lipid profile, oxidative stress, and inflammation biomarkers in adults: An umbrella meta-analysis of randomized controlled trials
Bahareh Sarmadi, Vali Musazadeh, Parvin Dehghan, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 10, pp. 1821-1835
Closed Access | Times Cited: 9

Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
World Journal of Gastroenterology (2022) Vol. 28, Iss. 39, pp. 5691-5706
Open Access | Times Cited: 14

Natural products and dietary interventions on liver enzymes: an umbrella review and evidence map
Zhongyu Li, Jiao Wu, Ying-pan Zhao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1

Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
Sandra G. García, Debora Rondinella, Francesca Romana Ponziani, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101924-101924
Closed Access | Times Cited: 1

Effect of cinnamon supplementation on blood pressure, oxidative stress, and inflammatory biomarkers in adults: An umbrella review of the meta-analyses of randomized controlled trials
Kaitian Zhang, Li Yang, Xuefeng Lin, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 12, pp. 2659-2668
Closed Access | Times Cited: 1

Probiotics modulation of the endotoxemic effect on the gut and liver of the lipopolysaccharide challenged mice
Gyan Babu, Banalata Mohanty
Drug and Chemical Toxicology (2024), pp. 1-17
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top